Filing Details
- Accession Number:
- 0000899243-20-015250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-04 16:24:49
- Reporting Period:
- 2020-06-02
- Accepted Time:
- 2020-06-04 16:24:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1552451 | Myokardia Inc. | MYOK | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1413822 | Anastasios Gianakakos | C/O Myokardia, Inc. 1000 Sierra Point Parkway Brisbane CA 94005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-06-02 | 600 | $100.60 | 28,522 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-02 | 800 | $101.72 | 27,722 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-02 | 1,396 | $102.78 | 26,326 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-02 | 1,885 | $103.77 | 24,441 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-02 | 319 | $104.64 | 24,122 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 129,407 | Indirect | By Reporting Person's Trust 2 |
Common Stock | 300,000 | Indirect | By Reporting Person's Trust 4 |
Common Stock | 7,000 | Indirect | By Reporting Person's Trust 5 |
Common Stock | 10,000 | Indirect | By Reporting Person's Trust 6 |
Common Stock | 53,087 | Indirect | By Trust 1 |
Common Stock | 53,087 | Indirect | By Trust 2 |
Common Stock | 53,087 | Indirect | By Trust 3 |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 3, 2019.
- Represents the weighted average sale price of the shares sold ranging from $100.27 to $101.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2, 3, 4, 5, and 6.
- Represents the weighted average sale price of the shares sold ranging from $101.28 to $102.17 per share.
- Represents the weighted average sale price of the shares sold ranging from $102.30 to $103.04 per share.
- Represents the weighted average sale price of the shares sold ranging from $103.30 to $104.10 per share.
- Represents the weighted average sale price of the shares sold ranging from $104.33 to $105.06 per share.